Budget impact analysis of utilizing canagliflozin (CANA) for the treatment of type 2 diabetes mellitus (T2DM) in an United States health plan
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1417
https://www.valueinhealthjournal.com/article/S1098-3015(14)01468-5/fulltext
Title :
Budget impact analysis of utilizing canagliflozin (CANA) for the treatment of type 2 diabetes mellitus (T2DM) in an United States health plan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01468-5&doi=10.1016/j.jval.2014.03.1417
First page :
A243
Section Title :
Diabetes/Endocrine Disorders I
Open access? :
No
Section Order :
896